In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review

M Otręba, L Kośmider - Journal of Applied Toxicology, 2021 - Wiley Online Library
Drug repositioning is an approach that could accelerate the clinical use of compounds in
different diseases. The goal is to take advantage of the fact that approved drugs have been …

In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.

M Otręba, L Kośmider - Journal of Applied Toxicology: JAT, 2020 - europepmc.org
Drug repositioning is an approach that could accelerate the clinical use of compounds in
different diseases. The goal is to take advantage of the fact that approved drugs have been …

In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review

M Otręba, L Kośmider - Journal of applied toxicology: JAT, 2021 - pubmed.ncbi.nlm.nih.gov
Drug repositioning is an approach that could accelerate the clinical use of compounds in
different diseases. The goal is to take advantage of the fact that approved drugs have been …

In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.

M Otręba, L Kośmider - Journal of Applied Toxicology, 2021 - search.ebscohost.com
Drug repositioning is an approach that could accelerate the clinical use of compounds in
different diseases. The goal is to take advantage of the fact that approved drugs have been …

In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review

M Otręba, L Kośmider - Journal of Applied Toxicology, 2020 - infona.pl
Drug repositioning is an approach that could accelerate the clinical use of compounds in
different diseases. The goal is to take advantage of the fact that approved drugs have been …